SSKN - STRATA Skin Sciences, Inc.
0.27
0.040 14.815%
Share volume: 23,506
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$0.23
0.04
0.17%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-13-2024 | 03-27-2025 | 05-14-2025 | 08-14-2025 | 11-14-2025 | |
| Assets | ||||||||
| Total Assets | 40.048 M | 39.581 M | 40.205 M | 36.157 M | 34.262 M | 30.722 M | 30.717 M | |
| Current Assets | 13.239 M | 13.825 M | 15.880 M | 16.595 M | 15.876 M | 13.774 M | 14.272 M | |
| Inventories | 2.695 M | 2.692 M | 2.744 M | 2.246 M | 2.659 M | 3.236 M | 3.058 M | |
| Other Current Assets | 343.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 343.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 3.630 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 5.237 M | 5.483 M | 7.062 M | 7.261 M | 6.512 M | 5.966 M | 7.076 M | |
| Total Non-current Assets | 26.809 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 11.726 M | 11.149 M | 10.387 M | 10.061 M | 9.462 M | 8.604 M | 9.557 M | |
| Other Assets | 231.000 K | 14.607 M | 13.938 M | 9.501 M | 8.924 M | 8.344 M | 6.888 M | |
| Intangible Assets | 6.825 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 6.519 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 40.048 M | 39.581 M | 40.205 M | 36.157 M | 34.262 M | 30.722 M | 30.717 M | |
| Total liabilities | 30.616 M | 30.085 M | 30.862 M | 31.185 M | 31.593 M | 30.414 M | 29.403 M | |
| Total current liabilities | 12.588 M | 12.133 M | 14.046 M | 14.625 M | 15.139 M | 14.004 M | 15.033 M | |
| Accounts Payable | 3.592 M | 2.886 M | 1.749 M | 2.433 M | 2.816 M | 2.945 M | 2.955 M | |
| Other liabilities | 1.601 M | 2.179 M | 1.098 M | 1.015 M | 931.000 K | 96.000 K | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 15.075 M | 15.114 M | 15.153 M | 15.192 M | 15.231 M | 15.270 M | 13.435 M | |
| Other liabilities | 1.601 M | 2.179 M | 1.098 M | 1.015 M | 931.000 K | 96.000 K | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 9.432 M | 9.496 M | 9.343 M | 4.972 M | 2.669 M | 308.000 K | 1.314 M | |
| Common stock | 35.061 M | 251.021 M | 252.990 M | 253.116 M | 253.245 M | 253.373 M | 255.777 M | |
| Retained earnings | -241.426 M | -241.525 M | -243.647 M | -248.144 M | -250.576 M | -253.065 M | -254.463 M |